Page 88 - GPD-4-3
P. 88

Gene & Protein in Disease                                          Dopaminergic dysfunction as pre-addiction

































            Figure 4. Enrichr-KG illustration of 27 candidate genes from five major databases: Gene Ontology, KEGG, Reactome, TRRUST, and DisGeNET. This
            integrative analysis identifies key genes and their associations with enriched biological processes, pathways, diseases, and transcriptional regulators: Gene
            Ontology: COMT, DRD2, DRD1, DRD3, and DRD4 are associated with the catecholamine metabolic process (GO:0006584); DPP4, DRD3, DRD4, DRD2,
            APOE, and TGFB1 are associated with the regulation of protein secretion (GO:0050708); DRD2, DRD1, DRD4, and DRD3 are associated with the regulation
            of dopamine uptake involved in synaptic transmission (GO:0051584); DRD4, DRD3, OPRM1, APOE, and DRD2 are associated with the negative regulation
            of protein secretion (GO:0050709); DRD4, COMT, DRD3, DRD1, MAOA, and DRD2 are associated with the dopamine metabolic process (GO:0042417).
            KEGG: DRD2, SLC6A3, MAOA, and DRD1 are involved in cocaine addiction; DRD3, DRD2, MAOA, DRD1, DRD4, SLC6A3, and COMT are involved in
            dopaminergic synapse; ADH1B, MAOA, TYR, and COMT are involved in tyrosine metabolism; DRD1, DRD2, MAOA, SLC6A3, and BAX are involved in
            Parkinson’s disease; DRD3, C5, CHRNA4, DRD2, DRD4, GABRA3, DRD1, and OPRM1 are involved in neuroactive ligand-receptor interaction. DisGeNET:
            gambling (pathological) is associated with DRD1, MAOA, DRD4, DRD3, COMT, SLC6A3, and DRD2; mental depression is associated with TGFB1, APOE,
            SLC6A3, BAX, ADH1B, DRD1, SLC6A4, MAOA, OPRM1, COMT, GABRA3, CHRNA4, DPP4, DRD4, DRD3, and DRD2; nicotine dependence is associated
            with SLC6A4, CHRNA4, ADH1B, SLC6A3, OPRM1, DRD3, COMT, DRD4, DRD2, MAOA, and DRD1; addictive behavior is associated with CHRNA4,
            COMT, DRD1, SLC6A4, MAOA, OPRM1, DRD4, DRD3, SLC6A3, BCL2, TGFB1, DRD2, and ADH1B; heroin dependence is associated with DRD4,
            SLC6A3, ADH1B, SLC6A4, COMT, MAOA, DRD1, DRD3, OPRM1, and DRD2. TRRUST: The transcription factor NFKB1 (human) regulates TGFB1,
            DRD2, BCL2, BAX, and OPRM1; ERCC2 (human) regulates BCL2 and BAX; NFKB1 (mouse) regulates APOE, TGFB1, DRD2, and BCL2; ABL1 (human)
            regulates BCL2 and BAX; POU4F1 (mouse) regulates BAX and BCL2. Reactome: DRD4, DRD2, OPRM1, DRD1, DRD3, C5, and CCL17 are involved in
            Class A/1 (rhodopsin-like receptors) (R-HSA-373076); SLC6A3, SLC6A4, GABRA3, MAOA, COMT, and CHRNA4 are involved in the transmission across
            chemical synapses (R-HSA-112315); DRD2, DRD3, DRD4, and DRD1 are invovled in amine ligand-binding receptors (R-HSA-375280); SLC6A3, MAOA,
            SLC6A4, and COMT are involved in neurotransmitter clearance (R-HSA-112311); DRD3, DRD1, DRD2, and DRD4 are involved in dopamine receptors
            (R-HSA-390651).

            100 GO terms across multiple studies. Notably, even after   One of the novel conceptualizations suggested for
            PGx refinement, the DA metabolic process (GO:0042417)   the inclusion of the preaddiction phenotype in the
            persisted as the most significantly enriched pathway.  Diagnostic and Statistical Manual of Mental Disorders is
                                                               the preaddiction construct, as juxtaposed to “prediabetes.”
                                                                                                             8
            4. Discussion                                      The American Diabetes Association defines prediabetes
                                                               as having abnormal insulin sensitivity (hemoglobin A1c:
            Emerging research in addiction biology has brought   5.7 – 6.4) and glucose tolerance levels (fasting blood
            attention to a novel conceptual framework called “pre-  glucose: 100 – 125 mg/dL; oral glucose tolerance test 2-h
            addiction.”  In this study, we hypothesize that our novel   blood glucose: 140 – 199 mg/dL).  Public health efforts
                    5,8
                                                                                           62
            PGx analysis strategy 54-61  has the potential to uncover new   around prediabetes have successfully leveraged early
            insights on opioid-induced pathology—specifically, that   detection,  third-party  payor  support,  and  preventative
            opioids may not only promote addictive behaviors but   interventions to delay or prevent progression to full-
            also accelerate the aging processes by inducing apoptosis   blown diabetes.  While prediabetes is a manifestation of
                                                                           63
            implicated in neurodegenerative disorders such as   failing microbiome homeostatic function, pre-addiction
            Alzheimer’s and Parkinson’s diseases.              may be linked to closely related hedonistic derailments,
                                                                                                            64

            Volume 4 Issue 3 (2025)                         6                               doi: 10.36922/gpd.8090
   83   84   85   86   87   88   89   90   91   92   93